Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlternative Liq Regulatory News (ALF)

Share Price Information for Alternative Liq (ALF)

Share Price is delayed by 15 minutes
Get Live Data
0.0215    0.00 (0.00%)
Bid:
0.003
Ask:
0.04
Spread: 0.037 (1,233.333%)
Market Cap: $3.14m
ALF Live PriceLast checked at - London Stock Exchange

Intraday Alternative Liq Share Chart

Portfolio Update

3 Jul 2025 09:45

RNS Number : 6117P
Alternative Liquidity Fund Limited
03 July 2025
 

ALTERNATIVE LIQUIDITY FUND LIMITED

Registered in Guernsey - Number 60552

LEI NUMBER 213800R5CHD76J3LU713

 

Registered Office:

1 Royal Plaza, Royal Avenue,

St Peter Port, Guernsey, GY1 2HL

 

3 July 2025

PORTFOLIO UPDATE

The Board and the Investment Adviser have received a positive update from Vision Brazil with regard to the FCVS RJ Fund. As previously communicated in the 2024 interim accounts and recent fact sheets, Vision and their advisers have been negotiating the FCVS RJ credits through the government system and have achieved some success. Over 80% of the credits in the portfolio which were approved by Caixa and officially handed over to the Treasury have now been novated. Having signed a novation contract with the Treasury, the related cash and bonds have been deposited into the V3 FIDC securities account.

A further tranche remains under review by the Treasury, and this may transition through to novation in the next several months.

With respect to the first novated tranche, Vision will now work with tax lawyers, service providers and the independent directors to determine and execute the following:

- the fiscal deductions that need to be settled in Brazil;

- the distribution waterfall approval;

- directors' resolution approval;

- execution of FIDC amortization;

- execution of FX transaction;

- transfer of funds among intermediate offshore vehicles; and

- sending notice of redemption to the Cayman administrator (Suntera); and

- Finally the joint authorization from Vision and Suntera for payment on behalf of each investor.

Vision estimates that the above steps will take approximately one month to complete. With respect to the waterfall of payments, we expect the V Invest RJ Loan to be settled in full first (ALF's share being circa US$2.67mlm), followed by the repayment of the recent US$3mln recapitalisation loan. The balance will then be distributed to all shareholders.

ALF owns 21.5% of the Vision RJ Fund and using an approximate estimate for the expected deductions that are listed above, we anticipate that ALF should receive a figure roughly equivalent to Vision's March 31, NAV for the RJ Fund. This was US$14.88mln.

We would like to re-iterate that this recovery estimate is an indicative guideline only. At this point we do not have accurate data with respect to the deductions listed above. Consequently, the recovery number could increase or decrease.

Based on the estimated timeline received from Vision, it is possible that this exercise could be completed prior to the end of August, however, accurate timing is difficult to ascertain at this point.

Once funds have been received, the Board will determine the appropriate amount of cash to be distributed through redeemable B shares. The Board will also take soundings from shareholders with a view to making recommendations with respect to the remaining assets in the portfolio.

Enquiries

 

Tim Gardner, Hindsight Solutions Limited

Tel. +44 7917 630 460

Email: timgardner@hindsightsolutions.co.uk

Website:   https://alternativeliquidityfund.com/

 

 

Apex Fund and Corporate Services (Guernsey) Limited

Telephone: +44 (0) 20 3530 3111

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUFIFVTDEIVIIE
Date   Source Headline
2nd Apr 20194:40 pmRNSSecond Price Monitoring Extn
2nd Apr 20194:35 pmRNSPrice Monitoring Extension
20th Mar 20193:30 pmRNSHalf-year Report
28th Feb 20195:00 pmRNSNet Asset Value and Fact Sheet 31 Dec 2018
25th Feb 20199:34 amRNSResult of Meeting
6th Feb 20194:48 pmRNSCircular and Notice of General Meeting
25th Jan 20193:00 pmRNSNet Asset Value and Fact Sheet 30 Nov 2018
25th Jan 20198:13 amRNSReturn of Capital - Replacement
24th Jan 20194:50 pmRNSReturn of Capital
9th Jan 20195:00 pmRNSNet Asset Value and Factsheet 31 October 2018
12th Dec 20184:17 pmRNSResult of AGM
7th Dec 20185:00 pmRNSNet Asset Value and Factsheet 28 September 2018
22nd Nov 20187:00 amRNSReturn of Capital
19th Nov 20184:40 pmRNSNet Asset Value and Fact Sheet 31 Aug 2018
29th Oct 20184:00 pmRNSAnnual Financial Report & Notice of AGM
17th Sep 20185:41 pmRNSPortfolio Update Sept 2018
5th Sep 20184:15 pmRNSNet Asset Value and Fact Sheet
22nd Aug 20184:40 pmRNSSecond Price Monitoring Extn
22nd Aug 20184:35 pmRNSPrice Monitoring Extension
26th Jul 20185:00 pmRNSNet Asset Value(s) and Fact Sheet 31 May 2018
27th Jun 20181:37 pmRNSDirector/PDMR Shareholding
26th Jun 20185:00 pmRNSNet Asset Value and Factsheet 30 April 2018
4th Jun 201811:40 amRNSHolding(s) in Company
1st Jun 20184:30 pmRNSNet Asset Value(s) and Fact sheet 29 March 2018
1st May 20185:00 pmRNSNet Asset Value and Fact sheet 28 February 2018
6th Apr 20182:19 pmRNSNet Asset Value(s) and Factsheet 31 January 2018
6th Apr 201811:00 amRNSUpdate and Return of Capital
29th Mar 20184:00 pmRNSHalf-year Report
2nd Mar 20182:00 pmRNSALF Net Asset Value and fact sheet 29 Dec 2017
1st Mar 201811:12 amRNSCompliance with Model Code
7th Feb 20183:00 pmRNSNet Asset Value & Fact Sheet 30 November 2017
24th Jan 20183:57 pmRNSHolding(s) in Company
23rd Jan 201811:51 amRNSNet Asset Value and fact Sheet 31 October 2017
22nd Dec 20171:11 pmRNSNet Asset Value and Fact Sheet 29 September 2017
18th Dec 20172:41 pmRNSResult of AGM
12th Dec 20174:06 pmRNSPortfolio Update
30th Nov 20174:08 pmRNSHolding(s) in Company
24th Nov 20174:40 pmRNSSecond Price Monitoring Extn
24th Nov 20174:35 pmRNSPrice Monitoring Extension
22nd Nov 20174:12 pmRNSPortfolio Update
7th Nov 20175:00 pmRNSNet Asset Value and Fact Sheet 31 August 2017
30th Oct 201711:55 amRNSReturn of Capital
30th Oct 20179:47 amRNSReturn of Capital
30th Oct 20177:00 amRNSAnnual Financial Report and AGM Notice
16th Oct 20174:40 pmRNSNet Asset Value and Fact Sheet 31 July 2017
3rd Oct 20171:41 pmRNSCompliance with Model Code
19th Sep 201711:39 amRNSPortfolio Update
8th Sep 20172:24 pmRNSNet Asset Value and Fact Sheet 30 June 2017
24th Jul 20173:32 pmRNSNet Asset Value and Fact Sheet 31 May 2017
6th Jul 20172:54 pmRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.